90349-40-9Relevant articles and documents
INHIBITORS OF THE MENIN-MLL INTERACTION
-
Page/Page column 96, (2018/04/14)
The present invention is directed to inhibitors of the interaction of menin with MLL and MLL fusion proteins, pharmaceutical compositions containing the same, and their use in the treatment of cancer and other diseases mediated by the menin-MLL interaction.
Amidine compounds
-
, (2008/06/13)
A compound of the formula [I] wherein R1, R2and R3are the same or different and each is hydrogen atom, wherein each symbol is as defined in the specification, a salt thereof or a prodrug thereof. The compound of the presen
Nitroaniline dyes with a cyano substituent group
-
, (2008/06/13)
The novel dye compound STR1 wherein R1 and R2, which may be the same or different except that R1 and R2 are not simultaneously hydrogen, are hydrogen, alkyl, hydroxyalkyl polyhydroxyalkyl, alkoxyalkyl, hydroxyalkoxyalkyl and amino alkyl, the alkyl group and the alkoxy group having from 1 to 6 carbons, and R3 is a compatible substituent group, for example, hydrogen, alkyl, hydroxy hydroxyalkyl and halogen. The dye compound is especially useful in hair dye compositions containing same.